KRRO · Categories · Form 4

KRRO - SEC Form 4 insider transactions

Korro Bio Inc. (KRRO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for KRRO

• 7d
  President and CEO Aiyar Ram sold $196,673 worth of shares (15,152 units at $12.98), decreasing direct ownership by 17% to 74,848 units (SEC Form 4) to satisfy withholding tax

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 8d
  Director Formela Jean Francois sold $39,897 worth of shares (2,860 units at $13.95) as part of a pre-agreed trading plan (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 12d
  President and CEO Aiyar Ram was granted 50,000 shares, increasing direct ownership by 125% to 90,000 units (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 68d
  SEC Form 4 filed by Lynx1 Capital Management Lp

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 89d
  Director Behbahani Ali was granted 207,100 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 126d
  President and CEO Aiyar Ram was granted 40,000 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 126d
  SEC Form 4 filed by Chief Scientific Officer Vincent Loic A

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 126d
  SEC Form 4 filed by Senior Vice President, Finance Dolan Oliver

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 126d
  SEC Form 4 filed by General Counsel Cerio Jeffrey

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 126d
  SEC Form 4 filed by Chief Operating Officer Chappell Todd

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 175d
  Chief Operating Officer Chappell Todd was granted 20,132 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 175d
  Chief Scientific Officer Vincent Loic A was granted 21,715 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 175d
  General Counsel Cerio Jeffrey was granted 41,902 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 175d
  Senior Vice President, Finance Dolan Oliver was granted 21,482 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 362d
  SEC Form 4 filed by Director Behbahani Ali

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 362d
  SEC Form 4 filed by Director Meyers Rachel

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 362d
  SEC Form 4 filed by Director Bermingham Nessan

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 362d
  SEC Form 4 filed by Director Knobil Katharine

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 362d
  SEC Form 4 filed by Director Formela Jean Francois

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 362d
  SEC Form 4 filed by Director Pearson Timothy R

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 433d
  SEC Form 4 filed by Chief Scientific Officer Vincent Loic A

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 433d
  SEC Form 4 filed by Senior Vice President, Finance Dolan Oliver

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 489d
  SEC Form 4 filed by General Counsel Cerio Jeffrey

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 489d
  SEC Form 4 filed by Chief Financial Officer Agarwal Vineet

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 489d
  SEC Form 4 filed by President and CEO Aiyar Ram

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 489d
  SEC Form 4 filed by Chief Operating Officer Chappell Todd

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 489d
  SEC Form 4 filed by Chief Medical Officer Olugemo Olukemi

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 574d
  Chief Financial Officer Agarwal Vineet exercised 800 shares at a strike of $11.68 and sold $56,000 worth of shares (800 units at $70.00) (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 599d
  Chief Financial Officer Agarwal Vineet sold $799,527 worth of shares (10,216 units at $78.26) and exercised 10,216 shares at a strike of $11.99 (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 644d
  SEC Form 4 filed by General Counsel Cerio Jeffrey

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 650d
  SEC Form 4 filed by Director Knobil Katharine

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 727d
  SEC Form 4 filed by Director Behbahani Ali

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 727d
  SEC Form 4 filed by Director Formela Jean Francois

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 727d
  SEC Form 4 filed by Director Meyers Rachel

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 727d
  SEC Form 4 filed by Director Pearson Timothy R

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 727d
  SEC Form 4 filed by Director Bermingham Nessan

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 727d
  SEC Form 4 filed by Director Lucchino David L.

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 735d
  SEC Form 4 filed by Olugemo Olukemi

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 776d
  Behbahani Ali was granted 17,857 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)
• 777d
  Formela Jean Francois was granted 17,857 shares (SEC Form 4)

  4 - Korro Bio, Inc. (0001703647) (Issuer)

Other KRRO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends